The lncRNA PCA3 [62] downregulated the expression of miR-218-5p, whose negative targeting of HMGB1 was evaluated in endometrial carcinoma [60], lung cancer [61], and prostate cancer [62], leading to a decrease in tumor proliferation, migration, invasion, and chemoresistance. Here, HMGB1 is linked to lung carcinoma.